Raras
Buscar doenças, sintomas, genes...
Síndrome hiper-IgM tipo 5
ORPHA:101092CID-10 · D80.5CID-11 · 4A01.05OMIM 608106DOENÇA RARA

Qualquer síndrome de hiper-IgM causada por uma mutação no gene UNG.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Qualquer síndrome de hiper-IgM causada por uma mutação no gene UNG.

Publicações científicas
789 artigos
Último publicado: 2026 Apr
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: D80.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🛡️
Imunológico
2 sintomas
🫁
Pulmão
1 sintomas
🩸
Sangue
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

100%prev.
Recombinação de troca de classe de Ig prejudicada
Frequência: 3/3
100%prev.
Infecções bacterianas recorrentes
Frequência: 3/3
100%prev.
Linfadenopatia
Frequência: 3/3
100%prev.
Nível diminuído de IgA circulante
Frequência: 3/3
100%prev.
Aumento do nível circulante de IgM
Frequência: 3/3
100%prev.
Nível diminuído de IgG circulante
Frequência: 3/3
11sintomas
Muito frequente (7)
Frequente (2)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 11 características clínicas mais associadas, ordenadas por frequência.

Recombinação de troca de classe de Ig prejudicadaImpaired Ig class switch recombination
Frequência: 3/3100%
Infecções bacterianas recorrentesRecurrent bacterial infections
Frequência: 3/3100%
LinfadenopatiaLymphadenopathy
Frequência: 3/3100%
Nível diminuído de IgA circulanteDecreased circulating IgA level
Frequência: 3/3100%
Aumento do nível circulante de IgMIncreased circulating IgM level
Frequência: 3/3100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico789PubMed
Últimos 10 anos200publicações
Pico201830 papers
Linha do tempo
2026Hoje · 2026🧪 2008Primeiro ensaio clínico📈 2018Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

Autosomal recessive
UNGUracil-DNA glycosylaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Uracil-DNA glycosylase that hydrolyzes the N-glycosidic bond between uracil and deoxyribose in single- and double-stranded DNA (ssDNA and dsDNA) to release a free uracil residue and form an abasic (apurinic/apyrimidinic; AP) site. Excises uracil residues arising as a result of misincorporation of dUMP residues by DNA polymerase during replication or due to spontaneous or enzymatic deamination of cytosine (PubMed:12958596, PubMed:15967827, PubMed:17101234, PubMed:22521144, PubMed:7671300, PubMed:

LOCALIZAÇÃO

MitochondrionNucleus

VIAS BIOLÓGICAS (4)
Chromatin modifications during the maternal to zygotic transition (MZT)Cleavage of the damaged pyrimidine Recognition and association of DNA glycosylase with site containing an affected pyrimidineDisplacement of DNA glycosylase by APEX1
MECANISMO DE DOENÇA

Immunodeficiency with hyper-IgM 5

A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
74.6 TPM
Linfócitos
54.0 TPM
Skin Sun Exposed Lower leg
51.6 TPM
Skin Not Sun Exposed Suprapubic
49.6 TPM
Testículo
48.5 TPM
OUTRAS DOENÇAS (1)
hyper-IgM syndrome type 5
HGNC:12572UniProt:P13051

Variantes genéticas (ClinVar)

40 variantes patogênicas registradas no ClinVar.

🧬 UNG: NM_080911.3(UNG):c.533+1G>T ()
🧬 UNG: GRCh37/hg19 12q23.1-24.33(chr12:99532287-133777902)x3 ()
🧬 UNG: NM_080911.3(UNG):c.348del (p.Phe117fs) ()
🧬 UNG: NM_080911.3(UNG):c.682del (p.Glu228fs) ()
🧬 UNG: NM_080911.3(UNG):c.551_552del (p.Lys184fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 277 variantes classificadas pelo ClinVar.

14
69
194
Patogênica (5.1%)
VUS (24.9%)
Benigna (70.0%)
VARIANTES MAIS SIGNIFICATIVAS
UNG: NM_080911.3(UNG):c.533+1G>T [Likely pathogenic]
UNG: NM_080911.3(UNG):c.397C>G (p.Gln133Glu) [Uncertain significance]
LOC130008712: NM_080911.3(UNG):c.114G>C (p.Glu38Asp) [Uncertain significance]
UNG: NM_080911.3(UNG):c.514C>A (p.Pro172Thr) [Uncertain significance]
UNG: NM_080911.3(UNG):c.570A>G (p.Ile190Met) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 31
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome hiper-IgM tipo 5

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
208 papers (10 anos)
#1

Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.

Clinical immunology (Orlando, Fla.)2026 Feb

Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder with microthrombocytopenia, eczema, immunodeficiency, autoimmunity and malignancies resulting from WAS pathogenic variants. Prevalence of disease in heterozygous female carriers has not been described previously. An online Qualtrics survey was designed in collaboration with the Wiskott-Aldrich Foundation, the Immune Deficiency Foundation, the Primary Immune Deficiency Treatment Consortium and Emory University to describe the incidence of thrombocytopenia, eczema, infections, autoimmune disorders, malignancies, and psychosocial factors. 193 carriers with a median age of 39 years participated in this survey. Respondents were predominantly White and were mothers of WAS patients. We observed a high prevalence of thrombocytopenia (13 %), eczema (22 %), infections (33 %) and autoimmunity (24 %) in this self-reported survey. No hematological malignancies were reported. Guilt (91 %), anxiety (41 %) and depression (44 %) were very prevalent. Comprehensive clinical and immunologic studies of WAS carriers should be prioritized to define appropriate health screening, preventive approaches, and counselling for carriers. SUMMARY: This self-reported survey describes the disease burden in 193 carriers of X-linked Wiskott-Aldrich syndrome. It highlights the increased incidence of thrombocytopenia, eczema, infections and autoimmunity in WAS carriers and the need for more comprehensive studies of WAS carriers. Primary immunodeficiencies are a heterogeneous group of inherited disorders affecting the immune system, with more than 450 distinct genetic defects identified to date. Patients with an X-linked immunodeficiency typically present with frequent and recurrent infections alongside immune dysregulation manifesting as autoimmunity, lymphoproliferation, granuloma formation, chronic inflammatory diseases, and increased susceptibility to malignancies. Among this group of disorders, 7 major X-linked immunodeficiency disorders have been well-characterized: X-linked chronic granulomatous disease (X-CGD), X-linked hyper-IgM syndrome, X-linked lymphoproliferative syndrome (XLP), Wiskott-Aldrich syndrome (WAS), X-linked severe combined immunodeficiency (X-SCID), X-linked agammaglobulinemia (XLA), and IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) syndrome. These conditions result in cellular or humoral immune deficiency, leading to serious infections and increased morbidity and mortality from early life. Identifying carriers remains challenging in the absence of family history, despite advances in genetic testing. CD40 ligand deficiency, a disorder of abnormal T- and B-cell function, is characterized by low serum concentrations of immunoglobulin (Ig) G, IgA, and IgE with normal or elevated serum concentrations of IgM. Mitogen proliferation may be normal, but NK- and T-cell cytotoxicity can be impaired. Antigen-specific responses are usually decreased or absent. Total numbers of B cells are normal but there is a marked reduction of class-switched memory B cells. Defective oxidative burst of both neutrophils and macrophages has been reported. The range of clinical findings varies, even within the same family. More than 50% of males with CD40 ligand deficiency develop symptoms by age one year, and more than 90% are symptomatic by age four years. CD40 ligand deficiency usually presents in infancy with recurrent upper- and lower-respiratory tract bacterial infections, opportunistic infections including Pneumocystis jirovecii pneumonia, and recurrent or protracted diarrhea that can be infectious or noninfectious and is associated with faltering growth. Neutropenia is common; thrombocytopenia and anemia are less commonly seen. Autoimmune and/or inflammatory disorders (such as sclerosing cholangitis) as well as increased risk for neoplasms have been reported as medical complications of this disorder. Significant neurologic complications, often the result of a central nervous system infection, are seen in 5%-15% of affected males. Liver disease, a serious complication of CD40 ligand deficiency once observed in more than 80% of affected males by age 20 years, may be decreasing with adequate screening and treatment of Cryptosporidium infection. The diagnosis of CD40 ligand deficiency is established in a male proband with typical clinical and laboratory findings and a hemizygous pathogenic variant in CD40LG identified by molecular genetic testing. Targeted therapy: Hematopoietic stem cell transplantation (the only curative treatment currently available) is ideally performed before age ten years or prior to evidence of organ dysfunction. Treatment of manifestations: Ig replacement therapy (either intravenous or subcutaneous); appropriate antimicrobial therapy for acute infections; antimicrobial prophylaxis for opportunistic infection against Pneumocysitis jirovecii pneumonia; recombinant granulocyte colony-stimulating factor for chronic neutropenia; immunosuppressants for autoimmune disorders. Agents/circumstances to avoid: Areas that place the affected individual at risk of contracting Cryptosporidium including pools, lakes, ponds, or certain water sources; drinking unpurified or unfiltered water; live vaccines such as rotavirus, MMR, varicella, live attenuated polio, and BCG. Surveillance: At least annually, complete blood count with differential to monitor for cytopenias, testing of IgG levels and lymphocyte subpopulations, and pulmonary function tests after age seven years. Regular assessment of liver function, with consideration of abdominal imaging, and polymerase chain reaction-based testing for the presence of enteric pathogens including Cryptosporidium. Monitor growth and general health with a low threshold for lymph node biopsy given elevated oncologic risk. Evaluation of relatives at risk: It is appropriate to clarify the genetic status of newborn at-risk male relatives of an affected individual to allow early diagnosis and prompt initiation of treatment and prevention of infections. CD40 ligand deficiency is inherited in an X-linked manner. The risk to sibs of a male proband depends on the genetic status of the mother. If the mother of the proband has a pathogenic variant in CD40LG, the chance of the mother transmitting it in each pregnancy is 50%: males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be heterozygotes. Heterozygous females are typically asymptomatic but may have a range of clinical manifestations depending on X-chromosome inactivation. Once the CD40LG pathogenic variant has been identified in an affected family member, heterozygote testing for at-risk female relatives and prenatal/preimplantation genetic testing for CD40 ligand deficiency are possible.

#2

A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.

BMC pediatrics2025 Nov 03

Activated PI3Kδ Syndrome (APDS) is a rare inborn error of immunity characterized by recurrent infections, lymphoproliferation, and autoimmunity. It results from mutations in the phosphoinositide 3-kinase delta (PI3Kδ) signalling pathway, leading to either gain-of-function (APDS1) or loss-of-function (APDS2) phenotypes. Clinical presentation ranges from asymptomatic to severe, depending on the underlying genetic defect. Malignancy, particularly lymphoma, represents the most frequent and life-threatening complication. Due to overlapping features with other primary immunodeficiencies, APDS is often misdiagnosed as combined immunodeficiency. Early molecular testing, particularly genetic analysis, is therefore crucial for accurate diagnosis. Although management remains complex and heterogeneous, there is growing interest in targeted approaches, particularly PI3Kδ-specific therapy. We describe a 12-year-old boy with recurrent respiratory and ear infections since infancy, accompanied by persistent lymphadenopathy, hepatosplenomegaly, and thrombocytopenia. Initial immunological evaluation suggested combined immunodeficiency, and prophylactic antibiotics were initiated, but genetic testing was deferred due to mild clinical features and parental reluctance. Following multiple years of enduring symptoms, genetic investigation identified a PIK3CD mutation leading in a missense alteration p.Glu1021Lys, confirming APDS 1. The patient was subsequently commenced on immunoglobulin replacement therapy and consulted for consideration of immunosuppressive and targeted pathway blocker therapy. This case highlights the diagnostic challenges of APDS, arising from both overlapping clinical features with other immunodeficiencies and external factors such as cost and parental decision-making. Early genetic testing facilitates accurate diagnosis, and timely recognition of APDS enables appropriate management, including immunosuppressive, targeted therapies and, in selected cases, potentially curative hematopoietic stem cell transplantation.

#3

Insights on SNPs of Human Activation-Induced Cytidine Deaminase AID.

International journal of molecular sciences2025 Jun 25

DNA-deaminase AID plays a pivotal role in adaptive immunity, antibody diversification and epigenetic regulation. AID catalyzes cytidine deamination in immunoglobulin genes, facilitating somatic hypermutation (SHM), class-switch recombination (CSR) and gene conversion (GC). However, the dysregulation of AID activity can lead to oncogenic mutations and immune disorders such as hyper-IgM syndrome type 2 (HIGM2). At present the number of studies investigating the role of AID polymorphic variants in the promotion of pathology is low. The current review examines the structural and functional aspects of AID, focusing on the impact of amino acid substitutions-both natural polymorphisms and artificial mutations-on its catalytic activity, substrate binding and interactions with regulatory proteins. Additionally, a bioinformatic analysis of single-nucleotide polymorphisms of AID deposited in the dbSNP database was performed. SNPs leading to amino acid substitutions in the primary protein structure were analyzed. The bioinformatic analysis of SNPs in the AID gene predicts that among 208 SNPs causing amino acid substitutions in the primary protein structure, 62 substitutions may have significant negative impact on the functioning of AID. The integration of computational predictions with experimental data underscores the importance of AID regulation in maintaining immune homeostasis and highlights potential markers for immune-related pathologies. This comprehensive analysis provides insights into the molecular mechanisms of AID dysfunction and its implications for disease.

#4

Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study.

The Lancet. Rheumatology2025 Apr

Systemic juvenile idiopathic arthritis-related lung disease (sJIA-LD) is a severe complication in patients with treatment-refractory systemic juvenile idiopathic arthritis (sJIA). The objective of this study was to evaluate the effect of allogeneic haematopoietic stem-cell transplantation (HSCT) in a cohort of children with sJIA-LD. This international, retrospective cohort study was performed in nine hospitals across the USA and Europe in children with sJIA-LD who had received allogeneic HSCT. Patients' medical charts were reviewed and their data extracted using a standardised form. The outcomes assessed were allogeneic HSCT outcomes (eg, engraftment and donor chimerism, and transplant-related complications), pulmonary outcomes (eg, oxygen dependence, chest CT findings, and pulmonary function test results), and overall outcomes (eg, death, complete response, or partial response). A complete response was defined as resolution of signs of sJIA without the need for systemic immunomodulatory therapy, in addition to discontinuation of supplemental oxygen. Between Jan 18, 2018, and Oct 17, 2022, 13 patients with sJIA-LD, who were refractory to immunosuppressive treatment and who had received an average of six different treatment agents, underwent allogeneic HSCT. Ten (77%) of 13 patients were female and three (23%) were male. The median age at diagnosis of sJIA-LD was 4·8 years (IQR 2·9-14·8) and the median age at transplantation was 9·0 years (5·0-19·0). Pre-HSCT chest CT revealed characteristic sJIA-LD. Five patients required supplemental oxygen before transplantation. Patients received various reduced toxicity or intensity conditioning regimens. Grafts were from 10/10 HLA-matched (n=6) or 9/10 HLA-mismatched (n=5) unrelated donors, a 7/10 related donor (n=1), and a matched sibling (n=1). All patients engrafted. One patient had secondary graft failure and received a second transplant from a different donor. Post-transplantation complications included acute graft-versus-host disease (n=5), bacteraemia (n=8), cytomegalovirus reactivation (n=6), and post-transplantation macrophage activation syndrome (n=3). Four patients died; two from cytomegalovirus pneumonitis, one from intracranial haemorrhage, and one from progressive sJIA-LD. At a median follow-up of 16 months (IQR 6-24), all nine surviving patients had a complete response, with no active features of sJIA, no biological therapy or corticosteroid use, and no supplemental oxygen dependence. Allogeneic HSCT might be a valuable treatment option for patients with refractory sJIA and sJIA-LD and should be considered for children with worsening oxygen dependence or severe treatment-related morbidity. National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR079525).

#5

Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge.

Infection and drug resistance2025

Talaromyces marneffei (TM), a temperature-dependent dimorphic fungus and opportunistic pathogen, poses a significant threat to immunocompromised individuals, particularly in Southeast Asian regions such as China and India. This case report details an 8-month-old HIV negative Chinese infant with recurrent cough and fever, who was diagnosed with TM infection through blood culture and metagenomic next-generation sequencing (mNGS). Additionally, whole exome sequencing identified a point mutation (c.346+1G>T) in the child's CD40LG gene, primary immunodeficiency calized to chromosome position chrX:135736590, leading to X-linked Hyper IgM Syndrome (XHIGM). The patient was managed with intravenous immunoglobulin (IVIG) and a 12-day course of amphotericin B and itraconazole, which led to significant clinical improvement and discharge on a quarterly IVIG regimen. However, he required readmission for recurrent TM pneumonia at 9 and 40 months post-discharge. This case highlights the diagnostic challenge and management complexity of TM infection in the context of primary immunodeficiency.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC288 artigos no totalmostrando 199

2025

Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge.

Infection and drug resistance
2026

Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.

Clinical immunology (Orlando, Fla.)
2025

Granulomatous and Lymphocytic Interstitial Lung Disease in Hyper-IgM Syndrome.

Scandinavian journal of immunology
2025

A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.

BMC pediatrics
2025

Acquired Renal Amyloidosis in a Patient With X-Linked Hyper-IgM Immunodeficiency With Novel Hemizygotic Pathogenic Variant in CD40LG Gene.

Case reports in nephrology
2025

Rare coexistence of X-linked hyper immunoglobulin M syndrome and polyarticular juvenile idiopathic arthritis in a Chinese child: A case report.

Joint diseases and related surgery
2025

Insights on SNPs of Human Activation-Induced Cytidine Deaminase AID.

International journal of molecular sciences
2025

Clinical relevance of loss-of-function mutations of NEMO/IKBKG.

Genes & diseases
2025

Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.

Frontiers in immunology
2025

Case Report: CD40LG Arg203Ile variant underlies atypical phenotype of X-linked hyper IgM syndrome.

Frontiers in immunology
2025

Non-tuberculous mycobacterial lymphadenitis in an infant with Hyper IgM Syndrome: A rare case report.

Diagnostic microbiology and infectious disease
2025

CD40 ligand: the essential link in B/T cell collaboration and immune activation.

Journal of immunology (Baltimore, Md. : 1950)
2025

Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls.

Frontiers in immunology
2024

Prolonged pediatric intensive care unit (PICU) admission, challenges in diagnosis and treatment in a child with hyper IgM syndrome in a tertiary hospital in Tanzania: a case report.

The Pan African medical journal
2024

Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report.

Biomedica : revista del Instituto Nacional de Salud
2025

Longitudinal monitoring of class-switched memory-B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders.

Cytometry. Part B, Clinical cytometry
2025

Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study.

The Lancet. Rheumatology
2024

Mechanotransduction governs CD40 function and underlies X-linked hyper-IgM syndrome.

Science advances
2025

Clinical and immunological features of four patients with activation-induced cytidine deaminase deficiency: Renal amyloidosis and other presentations.

Annals of human genetics
2024

Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases.

MedComm
2024

Antibody Response Before and After the Booster Dose of Inactivated Corona Vaccine in Antibody Deficient Patients.

Iranian journal of allergy, asthma, and immunology
2024

Orbital apex syndrome secondary to Pseudomonas aeruginosa sinusitis in a child with hyperimmunoglobulin M syndrome.

Pediatrics and neonatology
2024

A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families.

Immunogenetics
2024

A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome.

Journal of clinical immunology
2024

Compound Heterozygosity in Hyper‑IgM Syndrome Type 3: Case Report and Literature Review.

Journal of clinical immunology
2023

Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency.

Journal of clinical immunology
2024

Use of Metagenomic Next-Generation Sequencing in the Identification of Pneumocystis Jiroveci Pneumonia in a Previously Healthy Infant Diagnosed With X-Linked Hyper-IgM Syndrome.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
2024

Intramural Duodenal Hematoma in a Case of Hyper IgM Syndrome.

Journal of pediatric hematology/oncology
2023

Late diagnosis of X-linked hyper-IgM syndrome presenting as community-acquired Pseudomonas aeruginosa pneumonia-related septic shock.

Pediatric pulmonology
2023

Who's your data? Primary immune deficiency differential diagnosis prediction via machine learning and data mining of the USIDNET registry.

Clinical immunology (Orlando, Fla.)
2023

CD40L Activates Platelet Integrin αIIbβ3 by Binding to the Allosteric Site (Site 2) in a KGD-Independent Manner and HIGM1 Mutations Are Clustered in the Integrin-Binding Sites of CD40L.

Cells
2023

Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR-WHO Collaborative Study Phase-I.

Vaccines
2023

Elevated levels of enteric IgA in an unimmunised mouse model of Hyper IgM syndrome derived from gut-associated secondary lymph organs even in the absence of germinal centres.

Frontiers in cellular and infection microbiology
2023

Advanced computational analysis of CD40LG variants in atypical X-linked hyper-IgM syndrome.

Clinical immunology (Orlando, Fla.)
2023

Late-Onset Lymphopenia and ITP in a Patient with Hyper IgM Syndrome Due to a Homozygous Variant in AICDA.

Journal of clinical immunology
2023

[Hyper-IgM syndrome with early liver involvement].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2023

CD40LG-associated X-linked Hyper-IgM Syndrome (XHIGM) with pulmonary alveolar proteinosis: a case report.

BMC pediatrics
2023

Type 2 hyper-IgM syndrome with a rare variant of AICDA gene mutation in a young woman.

BMJ case reports
2023

Hyper-IgM and acquired C1q complement deficiency in a patient with de novo  ATM mutation.

Oxford medical case reports
2022

A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.

Scandinavian journal of immunology
2022

Progressive Multifocal Leukoencephalopathy With Hyper-IgM Syndrome in a 6-Year-Old Boy.

Brain & NeuroRehabilitation
2022

Case report: Hemophagocytic lymphohistiocytosis in a child with primary immunodeficiency infected with Talaromyces marneffei.

Frontiers in immunology
2023

X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.

Immunogenetics
2022

Respiratory infections in X-linked hyper-IgM syndrome with CD40LG mutation: a case series of seven children in China.

BMC pediatrics
2022

A Novel De Novo NFKBIA Missense Mutation Associated to Ectodermal Dysplasia with Dysgammaglobulinemia.

Genes
2022

Immunodeficiency Hiding in Plain Sight.

Cureus
2022

Somatic hypermutation defects in two adult hyper immunoglobulin M patients.

Immunologic research
2022

Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.

Frontiers in immunology
2022

Exome sequencing contributes to identify comorbidities in a rare case of infant ARDS induced by the CD40LG mutation.

BMC medical genomics
2022

Hyper IgM in tricho-hepato-enteric syndrome due to TTC37 mutation.

Immunologic research
2022

[Clinical effect of allogeneic hematopoietic stem cell transplantation in children with hyper-IgM syndrome].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2022

Utility of targeted next generation sequencing for inborn errors of immunity at a tertiary care centre in North India.

Scientific reports
2022

Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature.

Frontiers in immunology
2022

X-linked hyper IgM syndrome with severe eosinophilia: a case report and review of the literature.

BMC pediatrics
2022

Bronchial inflammation biomarker patterns link humoral immunodeficiency with bronchiectasis-related small airway dysfunction.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2022

Atypical Autosomal Recessive AID Deficiency-Yet Another Piece of the Hyper-IgM Puzzle.

Journal of clinical immunology
2022

Hyper-IgM syndrome resulting from heterozygous AICDA variants: A European first?

Scandinavian journal of immunology
2022

Progressive choreodystonia in X-linked hyper-IgM immunodeficiency: a rare but recurrent presentation.

Annals of clinical and translational neurology
2022

Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India.

Scientific reports
2022

A Novel AICDA Splice-Site Mutation in Two Siblings with HIGM2 Permits Somatic Hypermutation but Abrogates Mutational Targeting.

Journal of clinical immunology
2021

Case Report: Analysis of Preserved Umbilical Cord Clarified X-Linked Anhidrotic Ectodermal Dysplasia With Immunodeficiency in Deceased, Undiagnosed Uncles.

Frontiers in immunology
2021

Pulmonary Radiological Manifestations of Humoral and Combined Immunodeficiencies in a Tertiary Pediatric Center.

Iranian journal of allergy, asthma, and immunology
2021

Understanding neutropenia secondary to intrinsic or iatrogenic immune dysregulation.

Hematology. American Society of Hematology. Education Program
2023

Two novel CD40LG gene mutations causing X-linked hyper IgM syndrome in Vietnamese patients.

Clinical and experimental medicine
2022

A Novel Point-of-Care Rapid Diagnostic Test for Screening Individuals for Antibody Deficiencies.

Journal of clinical immunology
2021

Transient increased immunoglobulin levels in a hyper-IgM syndrome patient with COVID-19 infection.

Allergologia et immunopathologia
2022

X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia.

Journal of clinical immunology
2021

[Unrelated umbilical cord blood stem cell transplantation in the treatment of hyper-IgM syndrome caused by CD40 ligand gene mutation: a report of three cases and literature review].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2021

Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up.

Frontiers in pediatrics
2021

Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence.

Frontiers in pediatrics
2021

Cryptococcal Meningitis and Post-Infectious Inflammatory Response Syndrome in a Patient With X-Linked Hyper IgM Syndrome: A Case Report and Review of the Literature.

Frontiers in immunology
2022

Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.

Journal of Crohn's & colitis
2022

One-year intravenous immunoglobulin replacement therapy: efficacy in reducing hospital admissions in pediatric patients with Inborn Errors of Immunity.

Jornal de pediatria
2021

CD40LG mutations in Vietnamese patients with X-linked hyper-IgM syndrome; catastrophic anti-phospholipid syndrome as a new complication.

Molecular genetics & genomic medicine
2021

Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction.

Nucleic acids research
2021

Mitochondrial DNA insert into CD40 ligand gene-associated X-linked hyper-IgM syndrome.

Molecular genetics & genomic medicine
2021

Photoclinic: Cryptosporidiosis in Hyper IgM Syndrome.

Archives of Iranian medicine
2021

Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.

Journal of clinical immunology
2021

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome.

EMBO molecular medicine
2021

Domino donor lymphocyte infusion for secondary poor graft function after HLA-mismatched allogeneic stem cell transplantation between HLA-identical sibling pairs with congenital immunodeficiency.

Pediatric blood & cancer
2021

[Genetic analysis of a child with co-commitment progressive multifocal leukoencephalopathy and X-linked hyper IgM syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).

Immunological investigations
2021

Novel mutations in hyper-IgM syndrome type 2 and X-linked agammaglobulinemia detected in three patients with primary immunodeficiency disease.

Molecular genetics & genomic medicine
2021

Human Inborn Errors of Immunity (HIEI): predominantly antibody deficiencies (PADs): if you suspect it, you can detect it.

Jornal de pediatria
2021

Nodular Lymphoid Hyperplasia of the Rectum in a Patient With Primary Immunodeficiency.

The American journal of gastroenterology
2021

A novel activation-induced cytidine deaminase mutation in an adult with hyper-immunoglobulin M syndrome.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
2020

A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization.

Immunity
2020

Childhood choreoathetosis secondary to hyper-IgM syndrome (CD40 ligand deficiency).

Neurology(R) neuroimmunology & neuroinflammation
2021

Diagnosis of Hyper IgM syndrome in a Previously Healthy Adolescent Boy Presented with Cutaneous and Cerebral Cryptococcosis.

The Pediatric infectious disease journal
2020

Case Report: Hyper IgM Syndrome Identified by Whole Genome Sequencing in a Young Syrian Man Presenting With Atypical, Severe and Recurrent Mucosal Leishmaniasis.

Frontiers in immunology
2021

AA Amyloidosis Secondary to Primary Immune Deficiency: About 40 Cases Including 2 New French Cases and a Systematic Literature Review.

The journal of allergy and clinical immunology. In practice
2021

Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Brain & development
2021

Inflammatory aortitis in a patient with type 2 hyper IgM syndrome.

Rheumatology (Oxford, England)
2020

B Cell Disorders in Children: Part II.

Current allergy and asthma reports
2020

Hyper IgM Syndrome Type 2 Presenting as Intestinal Lymphoid Polyposis Without Recurrent Infection.

Journal of investigational allergology & clinical immunology
2020

Pulmonary Alveolar Proteinosis Due to Pneumocystis carinii in Type 1 Hyper-IgM Syndrome: A Case Report.

Frontiers in pediatrics
2021

Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome.

Immunological investigations
2020

Interstitial pneumonia as the initial presentation in an infant with a novel mutation of CD40 ligand-associated X-linked hyper-IgM syndrome: A case report.

Medicine
2020

Comprehensive RNA-Seq profiling of the lung transcriptome of Argali hybrid sheep in response to experimental Mycoplasma ovipneumoniae infection.

Research in veterinary science
2020

Complex preimplantation genetic tests for Robertsonian translocation, HLA, and X-linked hyper IgM syndrome caused by a novel mutation of CD40LG gene.

Journal of assisted reproduction and genetics
2020

From Dysgammaglobulinemia to Autosomal-Dominant Activation-Induced Cytidine Deaminase Deficiency: Unraveling an Inherited Immunodeficiency after 50 Years.

The Journal of pediatrics
2020

X-Linked Hyper IgM Syndrome Manifesting as Recurrent Pneumocystis jirovecii Pneumonia: A Case Report.

Journal of tropical pediatrics
2020

Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2020

Clinical implications of experimental analyses of AID function on predictive computational tools: Challenge of missense variants.

Clinical genetics
2020

[Immunodeficiency diseases with interstitial lung disease as major clinical manifestations: report of six cases].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2021

Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.

Immunological investigations
2019

A 23-Year-Old Man with Hyper-IgM Syndrome Presenting with Asymptomatic Violaceous Facial Plaques.

Dermatopathology (Basel, Switzerland)
2020

Diagnostic approach of hypogammaglobulinemia in infancy.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2020

X-Linked Hyper IgM Syndrome Presenting with Recurrent Tuberculosis-a Case Report.

Journal of clinical immunology
2019

Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2.

Frontiers in immunology
2019

X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene.

Immunologic research
2019

Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center.

BMC pediatrics
2019

Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated Talaromyces marneffei Infection in HIV-Negative Children.

Frontiers in immunology
2019

Hashimoto encephalopathy as manifestation of central nervous system chronic graft-versus-host disease after hematopoietic stem cell transplantation.

Pediatric blood & cancer
2019

FATAL cryptococcal meningitis in a child with hyper-immunoglobulin M syndrome, with an emphasis on the agent.

Journal de mycologie medicale
2020

A Novel CD40L Mutation Associated with X-Linked Hyper IgM Syndrome in a Chinese Family.

Immunological investigations
2019

Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling.

Journal of immunology (Baltimore, Md. : 1950)
2019

Respiratory Complications in Patients with Hyper IgM Syndrome.

Journal of clinical immunology
2019

Primary Immunodeficiency Disorders Among North Indian Children.

Indian journal of pediatrics
2019

Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in Iran.

International archives of allergy and immunology
2020

Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.

Clinical reviews in allergy & immunology
2019

Chronic Cholangiopathy Associated with Primary Immune Deficiencies Can Be Resolved by Effective Hematopoietic Stem Cell Transplantation.

The Journal of pediatrics
2019

PIK3R1 Mutation Associated with Hyper IgM (APDS2 Syndrome): A Case Report and Review of the Literature.

Endocrine, metabolic & immune disorders drug targets
2019

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India.

Journal of clinical immunology
2019

Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant: A case report.

Medicine
2019

Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome.

The Journal of allergy and clinical immunology
2019

CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives.

Expert review of clinical immunology
2019

Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.

The Journal of allergy and clinical immunology
2019

A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.

Clinical immunology (Orlando, Fla.)
2018

Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.

Transfusion
2019

A tetrameric form of CD40 ligand with potent biological activities in both mouse and human primary B cells.

Molecular immunology
2021

Disseminated cryptococcosis in two boys with novel mutation of CD40 Ligand-Associated X-linked hyper-IgM syndrome.

Asian Pacific journal of allergy and immunology
2019

The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.

Clinical immunology (Orlando, Fla.)
2019

Infectious etiology of chronic diarrhea in patients with primary immunodeficiency diseases.

European annals of allergy and clinical immunology
2018

An X-Linked Hyper-IgM Patient Followed Successfully for 23 Years without Hematopoietic Stem Cell Transplantation.

Case reports in immunology
2019

Posttransplant recipient-derived CD4+ T-cell lymphoproliferative disease in X-linked hyper-IgM syndrome.

Pediatric blood & cancer
2019

Primary B-cell immunodeficiencies.

Human immunology
2018

Pillars Article: Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme. Cell. 2000. 102: 553-563.

Journal of immunology (Baltimore, Md. : 1950)
2018

The Common Key to Class-Switch Recombination and Somatic Hypermutation: Discovery of AID and Its Role in Antibody Gene Diversification.

Journal of immunology (Baltimore, Md. : 1950)
2018

Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.

Frontiers in immunology
2018

Advances in site-specific gene editing for primary immune deficiencies.

Current opinion in allergy and clinical immunology
2019

Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort.

The journal of allergy and clinical immunology. In practice
2018

The RNA-binding protein ROD1/PTBP3 cotranscriptionally defines AID-loading sites to mediate antibody class switch in mammalian genomes.

Cell research
2018

Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.

Frontiers in immunology
2018

Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.

Immunological investigations
2018

Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.

Clinical immunology (Orlando, Fla.)
2018

No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency.

Frontiers in immunology
2018

Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.

Journal of clinical immunology
2018

Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran.

Scandinavian journal of immunology
2019

Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.

Bone marrow transplantation
2018

Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.

Cell reports
2018

A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases.

Frontiers in pediatrics
2018

Opportunistic fungal infection in children and management.

Current opinion in pediatrics
2018

Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome.

Journal of clinical immunology
2018

Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.

Frontiers in immunology
2019

X-linked hyper-IgM syndrome associated with pulmonary manifestations: A very rare case of functional mutation in CD40L gene in Iran.

Current research in translational medicine
2018

CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ.

The Journal of allergy and clinical immunology
2017

Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency.

Central-European journal of immunology
2018

50 Years Ago in The Journal of Pediatrics: Familial Granulocytopenia and Associated Immunoglobulin Abnormality: Report of 3 Cases in Young Brothers.

The Journal of pediatrics
2018

Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.

Cellular & molecular immunology
2018

Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child With CD40 Ligand Deficiency and Cryptosporidium-Induced Liver Cirrhosis.

Transplantation
2017

X-linked Hyper-IgM Syndrome: A Phenotype of Crohn's Disease with Hemophagocytic Lymphohistiocytosis.

Pediatric hematology and oncology
2017

Introduction: Antibody-Mediated Therapy Special Issue Part 2.

International immunology
2018

A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient.

Journal of clinical immunology
2017

A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child: A case report and literature review.

Medicine
2018

A Novel Mutation in CD40LG Gene Causing X-Linked Hyper IgM Syndrome.

Indian journal of pediatrics
2018

DOCK2 Deficiency in a Patient with Hyper IgM Phenotype.

Journal of clinical immunology
2018

Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.

Innate immunity
2018

Flow Cytometry Assays in Primary Immunodeficiency Diseases.

Methods in molecular biology (Clifton, N.J.)
2017

Inherited and acquired clinical phenotypes associated with neuroendocrine tumors.

Current opinion in allergy and clinical immunology
2018

Scalp Lesions in a Pediatric Patient with Hyper IgM Syndrome: Clinical and Histologic Mimicry of Cryptococcus neoformans Infection.

The Journal of pediatrics
2017

Activation-induced cytidine deaminase targets SUV4-20-mediated histone H4K20 trimethylation to class-switch recombination sites.

Scientific reports
2018

Liver disease predicts mortality in patients with X-linked immunodeficiency with hyper-IgM but can be prevented by early hematopoietic stem cell transplantation.

The Journal of allergy and clinical immunology
2017

[Clinical and immunological profile of 15 Moroccan patients with Hyper IgM syndrome].

The Pan African medical journal
2018

Flow cytometry-based diagnosis of primary immunodeficiency diseases.

Allergology international : official journal of the Japanese Society of Allergology
2017

Multicolor Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases.

Journal of clinical immunology
2017

Recent advances in the study of immunodeficiency and DNA damage response.

International journal of hematology
2016

Coexistence of Two Rare Autosomal Recessive Disorders: Activation-Induced Cytidine Deaminase Deficiency and Sjogren-Larsson Syndrome.

The Israel Medical Association journal : IMAJ
2017

First Case of CD40LG Deficiency in Ecuador, Diagnosed after Whole Exome Sequencing in a Patient with Severe Cutaneous Histoplasmosis.

Frontiers in pediatrics
2017

The clinical significance of complete class switching defect in Ataxia telangiectasia patients.

Expert review of clinical immunology
2017

Ataxia-telangiectasia: Immunodeficiency and survival.

Clinical immunology (Orlando, Fla.)
2017

Fatal Scopulariopsis brumptii in a Pediatric Immunocompromised Host.

Fetal and pediatric pathology
2016

Clinical Phenotypes of Hyper-IgM Syndromes.

The journal of allergy and clinical immunology. In practice
2016

[Recurrent fever, hepatosplenomegaly and eosinophilia in a boy].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2017

Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.

Allergologia et immunopathologia
2016

Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.

Molecular immunology
2017

Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

The Journal of allergy and clinical immunology
2016

Ataxia telangiectasia presenting as hyper IgM syndrome without neurologic signs.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
2016

Hyper IgM Syndrome with low IgM and thrombocytosis: an unusual case of immunodeficiency.

European annals of allergy and clinical immunology
2017

Prospective evaluation of Streptococcus pneumoniae serum antibodies in patients with primary immunodeficiency on regular intravenous immunoglobulin treatment.

Allergologia et immunopathologia
2016

X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis.

Journal of clinical immunology
2016

Bronchus-associated Lymphoid Tissue in Kabuki Syndrome with Associated Hyper-IgM Syndrome/Common Variable Immunodeficiency.

American journal of respiratory and critical care medicine
2016

Structural analysis of the activation-induced deoxycytidine deaminase required in immunoglobulin diversification.

DNA repair
2016

Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.

The Journal of allergy and clinical immunology
2016

Hyper IgM Syndrome: a Report from the USIDNET Registry.

Journal of clinical immunology
2016

[Primary hypogammaglobulinemia complicated with liver cirrhosis and literature review].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2016

Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland.

European journal of human genetics : EJHG
2016

Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature.

Journal of clinical immunology
2016

p85α is an intrinsic regulator of human natural killer cell effector functions.

The Journal of allergy and clinical immunology
Ver todos os 288 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome hiper-IgM tipo 5.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome hiper-IgM tipo 5

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.
    Clinical immunology (Orlando, Fla.)· 2026· PMID 41419161mais citado
  2. A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.
    BMC pediatrics· 2025· PMID 41184801mais citado
  3. Insights on SNPs of Human Activation-Induced Cytidine Deaminase AID.
    International journal of molecular sciences· 2025· PMID 40649888mais citado
  4. Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study.
    The Lancet. Rheumatology· 2025· PMID 39718183mais citado
  5. Recurrent Talaromyces Marneffei Infection Revealing X-Linked Hyper IgM Syndrome in an HIV-Negative Infant: A Diagnostic and Therapeutic Challenge.
    Infection and drug resistance· 2025· PMID 41451037mais citado
  6. Hyper-IgM Syndrome.
    Ann Allergy Asthma Immunol· 2026· PMID 41936419recente
  7. Occurrence of eruptive cutaneous capillary haemangiomas in a teenager with hyper IgM syndrome.
    Indian J Dermatol Venereol Leprol· 2025· PMID 41655092recente
  8. Sensitive and unbiased genome-wide profiling of base-editor-induced off-target activity using CHANGE-seq-BE.
    Nat Biotechnol· 2026· PMID 41482541recente
  9. X-Linked Immunodeficiency.
    · 2026· PMID 32965853recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:101092(Orphanet)
  2. OMIM OMIM:608106(OMIM)
  3. MONDO:0011971(MONDO)
  4. GARD:10581(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q5957527(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome hiper-IgM tipo 5

ORPHA:101092 · MONDO:0011971
CID-10
D80.5 · Imunodeficiência com aumento de imunoglobulina M [IgM]
CID-11
MedGen
UMLS
C1720958
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades